Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Treatment adherence in patients with multiple sclerosis: risk factors
L.A. Rodríguez de Antonio; R. Fernández de Córdoba-García; N. Herrero-Muñoz; A. Ontañón-Nasarre; I. García-Castañón;
Neurologia. 2025;40:353-60
A comparative study of melatonin and immunomodulatory therapy with interferon beta and glatiramer acetate in a mouse model of multiple sclerosis
E.J. Ramos González; L.J. Ramirez Jirano; D.Z. García Martínez; G.G. Ortiz; L.F. Jave Suárez; C.A. Leal Cortes; O.K. Bitzer Quintero;
Neurologia. 2021;36:262-70
Impact of fatigue on quality of life in adults with multiple sclerosis
R. Piñar-Morales; P.A. Guirado-Ruiz; F.J. Barrero Hernández;
Neurologia. 2025;40:864-74